Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides., PMID:40476553
[A fluorescence immunochromatography method for detection of human papillomavirus type 16 E6 and L1 proteins]., PMID:39584350
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers., PMID:38978164
Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells., PMID:38967656
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector., PMID:38858404
Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status., PMID:38577820
Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion., PMID:38415538
Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study., PMID:37994805
Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein., PMID:37582106
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers., PMID:37104874
Human papillomavirus is an important risk factor for esophageal carcinoma in a Chinese population., PMID:36394699
Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study., PMID:36322543
Human papillomavirus, tobacco, and poor oral hygiene can act synergetically, modulate the expression of the nuclear factor kappa B signaling pathway for the development and progression of head and neck cancer in the Pakistani population., PMID:35838554
Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis., PMID:35641882
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial., PMID:33271094
Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank., PMID:33248371
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)., PMID:32816895
Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells., PMID:32399935
Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362
Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma., PMID:32170783
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670
Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population., PMID:31860383
Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis., PMID:31226168
Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies., PMID:30894687
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer., PMID:30353680
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer., PMID:30242022
Prediction and identification of human leukocyte antigen-A2-restricted cytotoxic T lymphocyte epitope peptides from the human papillomavirus 58 E7 protein., PMID:30008894
Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer., PMID:29938318
Performance of OncoE6 cervical test with collection methods enabling self-sampling., PMID:29783960
Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model., PMID:28599791
A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia., PMID:27764154
Generation of affibody molecules specific for HPV16 E7 recognition., PMID:27659535
Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity., PMID:27485136
Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care., PMID:27175798
Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis., PMID:26529033
A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]., PMID:26242403
No causal association identified for human papillomavirus infections in lung cancer., PMID:24760422
Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer., PMID:24729277
Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis., PMID:24696483
Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancer., PMID:24648924
High-risk HPV types and head and neck cancer., PMID:24615247
Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment., PMID:23953057
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer., PMID:23775966
Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study., PMID:23503618
Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18., PMID:23233027
High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner., PMID:23175360
Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo., PMID:23128977
The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma., PMID:22923266
For research use only. Not for human or drug use.
